Trial Profile
A study comparing efficacy of denosumab versus bisphosphonates in patients with rheumatoid arthritis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Jan 2017
Price :
$35
*
At a glance
- Drugs Denosumab (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- 24 Aug 2016 New trial record